How should antibiotic‑induced diarrhea be managed?

Managing Antibiotic-Induced Diarrhea

The first and most critical step is to discontinue the offending antibiotic as soon as clinically feasible, as this alone may resolve symptoms and reduce recurrence risk. 1

Initial Assessment and Triage

When a patient develops diarrhea during or after antibiotic therapy, immediately assess for:

• Severity markers: Fever, bloody stools, severe abdominal pain, signs of dehydration, or systemic toxicity suggest Clostridioides difficile infection (CDI) or other serious complications 1, 2
• Dehydration status: Evaluate pulse, perfusion, mental status, and orthostatic vital signs 3
• Timing and context: Diarrhea occurring during hospitalization or in elderly patients carries higher CDI risk 2

Fluid and Electrolyte Management

Rehydration is the cornerstone of supportive care and takes priority over all other interventions. 3

Mild to Moderate Dehydration

• Use reduced osmolarity oral rehydration solution (ORS) as first-line therapy for all patients with mild to moderate dehydration 3
• Continue ORS until clinical dehydration is corrected and ongoing losses cease 3
• Resume age-appropriate diet immediately after rehydration is complete 3

Severe Dehydration

• Administer isotonic intravenous fluids (lactated Ringer's or normal saline) when severe dehydration, shock, altered mental status, or ileus is present 3
• Continue IV rehydration until pulse, perfusion, and mental status normalize 3
• Transition to ORS for remaining deficit replacement once patient can tolerate oral intake 3

Ruling Out Clostridioides difficile Infection

If the patient has fever, bloody diarrhea, severe abdominal pain, or is hospitalized/elderly, test for CDI immediately. 1, 2

• Start empiric CDI treatment if substantial delay in laboratory confirmation is expected (>48 hours) or if fulminant disease is suspected 1
• For confirmed initial CDI episode, use vancomycin 125 mg orally 4 times daily OR fidaxomicin 200 mg twice daily for 10 days (vancomycin and fidaxomicin are preferred over metronidazole) 1
• Metronidazole 500 mg orally 3 times daily for 10 days may be used only for nonsevere CDI when vancomycin/fidaxomicin access is limited, but avoid repeated courses due to neurotoxicity risk 1

Symptomatic Management for Non-CDI Antibiotic-Associated Diarrhea

Antimotility Agents

• Loperamide may be given to immunocompetent adults with acute watery diarrhea once adequate hydration is achieved 3
• Never use antimotility drugs in children <18 years of age 3
• Avoid loperamide at any age if inflammatory diarrhea, fever, or bloody stools are present due to toxic megacolon risk 3
• Antimotility agents are adjuncts only and never substitute for fluid/electrolyte therapy 3

Antiemetics

• Ondansetron may be given to children >4 years and adolescents with vomiting to facilitate oral rehydration tolerance 3

Probiotic Therapy

Probiotics may be offered to reduce symptom severity and duration in immunocompetent adults and children with antibiotic-associated diarrhea. 3

However, there are important caveats:

• The 2017 IDSA Infectious Diarrhea Guidelines support probiotics for antibiotic-associated diarrhea with weak/moderate evidence 3
• The 2018 IDSA/SHEA CDI Guidelines found insufficient data to recommend probiotics for primary CDI prevention, citing study limitations and potential for probiotic-related infections in hospitalized patients 1
• If using probiotics, select specific strains with evidence from literature searches or manufacturer guidance 3

Additional Considerations

Empiric Antimicrobial Therapy

• Do not give empiric antimicrobial therapy for most cases of acute watery diarrhea without recent international travel 3
• Exceptions include immunocompromised patients or ill-appearing young infants 3

Nutritional Support

• Continue breastfeeding in infants throughout the diarrheal episode 3
• Resume normal diet as soon as rehydration is complete 3

Infection Control

• Practice rigorous hand hygiene with soap and water (alcohol-based sanitizers may be insufficient for CDI spores) 3
• Use gloves and gowns when caring for patients with diarrhea 3

Common Pitfalls to Avoid

• Never delay discontinuation of the causative antibiotic, as continued use decreases clinical response and increases recurrence 1
• Never use antimotility agents in children or when inflammatory/infectious causes are suspected 3
• Never substitute symptomatic treatments for adequate fluid and electrolyte replacement 3
• Do not use metronidazole for repeated or prolonged CDI courses due to cumulative neurotoxicity risk 1